Teva Pharmaceutical (NASDAQ:TEVA) rose to its highest level in almost six months on news that Ranbaxy Laboratories picked up market share in with its Lipitor...
We interview Tara Nash of TEVA Pharmaceuticals about their pharmaceutical manufacturing company and the opportunities for students in Oxford College's pharmaceutical programs to be part...
Morgan Stanley upgraded Teva Pharmaceutical Industries (NASDAQ:TEVA) to overweight from equal-weight andmaintained its $47 price target. The bank sees 2011 EPS of $4.97, up from...
Teva Pharmaceutical (NASDAQ:TEVA)reported Q3 EPS of $1.25, ex-items, ahead of consensus estimates of $1.22 per share. Revenues for the quarter rose 2.2% year-over-year to $4.34...
Welcome to CRWENewswire, Stocks to Watch. I am Shalika Jayasekera Tutor Perini Corporation - symbol TPC - reported that its subsidiary, Perini Management Services, Inc.,...
We're extremely proud to showcase our latest Cleverwrite™ Dry Erase Wall Covering installation for TEVA UK in collaboration with Chilli, UK - one of the...
www.tevapharm.com hebrew.tevapharm.com Teva Pharmaceutical Industries Ltd. (Hebrew: טבע תעשיות פרמצבטיות בע"מ), NASDAQ: TEVA is an international pharmaceutical company headquartered in Petah Tikva, Israel. It specializes...
Teva Pharmaceutical (NASDAQ:TEVA) announced that it will acquire the 50% interest formerly held by Kowa Company Ltd. in Teva's Japanese joint venture for a total...
